logo

Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)

Sector: Hospital • Location: United States of America

Source: Grants.gov

Project
Forecasted

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research to support and facilitate multidisciplinary research approaches for the development or improvement of technologies - including but not limited to drugs, devices, products, or clinical practices - designed to impro

Project Information FAQ

Project Information

5 Q
The project “Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

forecasted

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research to support and facilitate multidisciplinary research approaches for the development or improvement of technologies - including but not limited to drugs, devices, products, or clinical practices - designed to improve fertility outcomes in patients dealing with infertility, particularly in the context of assisted reproductive technologies (ART). Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize a phased R61/R33 mechanism and aims to position innovative and validated technologies for future clinical development.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data